PRRUF
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Feb 18 closing price
Capitalization
238.01M
PVCT
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
41.9M
Ad is loading...

PRRUF vs PVCT

Header iconPRRUF vs PVCT Comparison
Open Charts PRRUF vs PVCTBanner chart's image
Immutep
Price$0.20
Change-$0.00 (-0.00%)
Volume$5K
Capitalization238.01M
Provectus Biopharmaceuticals
Price$0.10
Change-$0.00 (-0.00%)
Volume$352.14K
Capitalization41.9M
PRRUF vs PVCT Comparison Chart
Loading...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRRUF vs. PVCT commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRRUF is a Buy and PVCT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (PRRUF: $0.20 vs. PVCT: $0.10)
Brand notoriety: PRRUF and PVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRRUF: 131% vs. PVCT: 150%
Market capitalization -- PRRUF: $238.01M vs. PVCT: $41.9M
PRRUF [@Biotechnology] is valued at $238.01M. PVCT’s [@Biotechnology] market capitalization is $41.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRRUF’s FA Score shows that 0 FA rating(s) are green whilePVCT’s FA Score has 1 green FA rating(s).

  • PRRUF’s FA Score: 0 green, 5 red.
  • PVCT’s FA Score: 1 green, 4 red.
According to our system of comparison, PVCT is a better buy in the long-term than PRRUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PVCT’s TA Score shows that 5 TA indicator(s) are bullish.

  • PVCT’s TA Score: 5 bullish, 3 bearish.

Price Growth

PRRUF (@Biotechnology) experienced а 0.00% price change this week, while PVCT (@Biotechnology) price change was -0.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.30%. For the same industry, the average monthly price growth was -17.15%, and the average quarterly price growth was -18.93%.

Reported Earning Dates

PVCT is expected to report earnings on Nov 18, 2024.

Industries' Descriptions

@Biotechnology (-11.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRRUF($238M) has a higher market cap than PVCT($41.9M). PRRUF YTD gains are higher at: -1.937 vs. PVCT (-16.986). PVCT has higher annual earnings (EBITDA): -2.78M vs. PRRUF (-43.83M). PRRUF has more cash in the bank: 159M vs. PVCT (187K). PRRUF has less debt than PVCT: PRRUF (1.69M) vs PVCT (2.8M). PRRUF (0) and PVCT (0) have equivalent revenues.
PRRUFPVCTPRRUF / PVCT
Capitalization238M41.9M568%
EBITDA-43.83M-2.78M1,574%
Gain YTD-1.937-16.98611%
P/E RatioN/AN/A-
Revenue00-
Total Cash159M187K85,027%
Total Debt1.69M2.8M60%
FUNDAMENTALS RATINGS
PRRUF vs PVCT: Fundamental Ratings
PRRUF
PVCT
OUTLOOK RATING
1..100
425
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
7279
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVCT's Valuation (4) in the null industry is significantly better than the same rating for PRRUF (85). This means that PVCT’s stock grew significantly faster than PRRUF’s over the last 12 months.

PVCT's Profit vs Risk Rating (61) in the null industry is somewhat better than the same rating for PRRUF (100). This means that PVCT’s stock grew somewhat faster than PRRUF’s over the last 12 months.

PRRUF's SMR Rating (96) in the null industry is in the same range as PVCT (100). This means that PRRUF’s stock grew similarly to PVCT’s over the last 12 months.

PRRUF's Price Growth Rating (72) in the null industry is in the same range as PVCT (79). This means that PRRUF’s stock grew similarly to PVCT’s over the last 12 months.

PRRUF's P/E Growth Rating (100) in the null industry is in the same range as PVCT (100). This means that PRRUF’s stock grew similarly to PVCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PVCT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENB45.340.20
+0.44%
Enbridge
SKWD54.02-0.62
-1.13%
Skyward Specialty Insurance Group
ADUR4.98-0.10
-1.97%
Aduro Clean Technologies Inc
ERAS1.21-0.05
-3.97%
Erasca
LPX87.21-6.48
-6.92%
Louisiana-Pacific Corp

PRRUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRRUF has been loosely correlated with IMMP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRRUF jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRRUF
1D Price
Change %
PRRUF100%
N/A
IMMP - PRRUF
43%
Loosely correlated
-3.59%
CALC - PRRUF
24%
Poorly correlated
-1.08%
PHGUF - PRRUF
21%
Poorly correlated
N/A
PVCT - PRRUF
11%
Poorly correlated
N/A
OXBDF - PRRUF
9%
Poorly correlated
N/A
More

PVCT and

Correlation & Price change

A.I.dvisor tells us that PVCT and LABFF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVCT and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVCT
1D Price
Change %
PVCT100%
N/A
LABFF - PVCT
23%
Poorly correlated
N/A
RVPH - PVCT
20%
Poorly correlated
+0.32%
PPTDF - PVCT
17%
Poorly correlated
N/A
PTIX - PVCT
12%
Poorly correlated
+84.14%
PRRUF - PVCT
11%
Poorly correlated
N/A
More